Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the COVID-Omega-F TrialPhysiology Published on 2021-01-112022-10-31 Journal: Frontiers in Physiology [Category] COVID-19, [키워드] acid acute respiratory syndrome addition arachidonic acid cardiovascular complications cause clinical trial contribute coronavirus coronavirus disease COVID-19 COVID-19 patient Cytokine release syndrome Cytokines Eicosanoids fatty feasibility immune response Inflammation inflammatory reaction limit lipid mediator local inflammation lung Omega-3 fatty acids omega-3 PUFA omega-3 PUFA supplementation placebo-controlled Polyunsaturated pro-inflammatory Randomized rationale reported Resolution resolution of inflammation Respiratory failure SARS-CoV-2 Severe case single-blind Stimulating storm Study protocol systemic hyperinflammatory reaction systemic inflammation Trial Trigger [DOI] 10.3389/fphys.2020.624657 PMC 바로가기 [Article Type] Physiology
Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial입원한 중증 COVID-19 환자를 위한 치료제로서의 정맥내 메틸프레드니솔론 펄스: 무작위 대조 임상 시험의 결과Randomized Controlled Trial Published on 2020-12-242022-08-13 Journal: The European Respiratory Journal [Category] 임상, [키워드] 1:1 95% CI administration Analysis attending physician Block randomisation Clinical improvement clinical trial conducted Controlled clinical trial Corticosteroid Corticosteroids COVID-19 COVID-19 patient COVID-19 patients death demonstrated eligible patient hazard ratio hospitalised hospitalised patient Immunosuppressive treatment Inflammation Inflammatory marker inflammatory markers initiation of treatment intention-to-treat Intravenous injection Iran ITT log-rank test Methylprednisolone methylprednisolone group mortality rate oxygen oxygen saturation Patient pulmonary involvement pulse randomisation randomised controlled Randomly receive reduce respiratory Respiratory system Result safety analysis severe adverse event severe adverse events severe COVID-19 severe COVID-19 patient significantly increased significantly lower single-blind standard care standard care group suggested survival survival time therapeutic therapeutic agent Treatment Two patient two patients was done were excluded [DOI] 10.1183/13993003.02808-2020 PMC 바로가기 [Article Type] Randomized Controlled Trial
The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial입원한 COVID-19 환자의 결과 개선에 대한 파모티딘의 효능: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약Letter Published on 2020-10-132022-08-13 Journal: Trials [Category] MERS, SARS, 임상, [키워드] Alanine Alanine transaminase alcoholism All participant All participants allergies allergy allocation approved ARMS aspartate Aspartate transaminase assigned assumption Bandar Abba Bandar Abbas baseline Blinding block randomization blood count Care Chronic kidney disease clearance clinical clinical trial clinical trials code Committee company comparator Comparator group complete blood count concealed control group control groups COVID-19 COVID-19 patient COVID-19 patients creatinine creatinine clearance criteria Dasatinib dialysis discharge dissemination dosage drug therapy electrocardiogram element eligibility criteria End-stage renal disease ethics committee Evidence evidence of excluded expected Famotidine G6PD Glucose Glucose 6 phosphate grouping groups Hepatitis hepatitis C Hospitalized Immunocompromised Immunocompromised patients Infection Intervention Kidney disease Lactate lactate dehydrogenase lead limit Liver disease Local lung infiltration maximum Medical Science Medical Sciences moderate need for dialysis Neratinib normal limit number objective online tool oral contraceptives outcome outcome assessor outcome assessors oxygen oxygen saturation Ozanimod participant Patient patients patients with COVID-19 Pazopanib PCR test pharmaceutical Pharmaceutical Company phosphate Placebo placebo-controlled porphyria positive Pregnancy protocol psoriasis random randomisation randomised randomised controlled trial randomized clinical trial Randomly randomly divided receive recruitment Registered registry renal renal disease renal failure reported Research question researcher respiration rate responsible Rilpivirine Sample size sample size calculation sequence sequence information single-blind Siponimod Standard study drug Study protocol subject submitted technology temperature the ethics committee therapy title Tizanidine transaminase Treatment treatment group Treatment protocol treatment protocols Trial registration two group two groups university Version website were measured written consent [DOI] 10.1186/s13063-020-04773-6 PMC 바로가기 [Article Type] Letter
Fortified whey beverage for improving muscle mass in chronic obstructive pulmonary disease: a single-blind, randomized clinical trial만성 폐쇄성 폐질환의 근육량 개선을 위한 강화 유청 음료: 단일 맹검, 무작위 임상 시험Research Published on 2020-08-172022-09-06 Journal: Respiratory Research [Category] Communicable Disease, [키워드] analyzed Bioelectrical Impedance Analysis Body body composition body protein Cachexia calculated change changes in chronic obstructive Concentration concentrations conducted control group COPD Cytokines Effect effective Efficacy fat-free mass fortified glutathione handgrip strength IL-6 Inflammation Inflammatory cytokine Inflammatory cytokines interleukin Intervention intervention group life Lung diseases Magnesium Malnutrition malondialdehyde muscle mass Muscle strength Necrosis nutritional intervention nutritional supports obstructive pulmonary diseases participant Patient Primary outcome Primary outcomes progression pulmonary disease Quality of life randomized clinical trial randomized trial Result secondary outcome Secondary outcomes serum serum concentrations significant changes in significant decrease significantly single-blind Skeletal muscle suggested Support TNFα Tumor tumor necrosis tumor necrosis factor two groups variables Vitamin Vitamin C was performed were measured whey [DOI] 10.1186/s12931-020-01466-1 PMC 바로가기 [Article Type] Research
Effects of Spirulina platensis supplementation on lipid profile in HIV–infected antiretroviral naïve patients in Yaounde – Cameroon: a randomized trial study야운데 - 카메룬에서 HIV에 감염된 항레트로바이러스 경험이 없는 환자의 지질 프로필에 대한 스피루리나 플라텐시스 보충제의 효과: 무작위 시험 연구Research Published on 2014-12-132022-09-06 Journal: Lipids in Health and Disease [Category] Communicable Disease, [키워드] abnormality age alteration antiretroviral Atherosclerosis average average age balanced diet baseline BMI body fat body mass body mass index cardiovascular cardiovascular diseases cardiovascular dysfunction cardiovascular risk factors CD4 cholesterol conducted contributing to CVD defined determine disease dyslipidemia Effect Factor fat distribution female Food Intake HDL-C HDL-cholesterol HIV HIV+ antiretroviral naïve include infections Inflammation insulin insulin resistance LDL-C LDL-cholesterol lipid profile Local local food majority metabolic syndrome multicentre naïve participant Patient patients public health Quantitative Randomized randomized trial recruited reported Result screened significant decrease significant increase significantly single-blind Spirulina platensis syndrome the patient Total cholesterol Triglyceride triglycerides variable weight were assessed with HIV [DOI] 10.1186/1476-511X-13-191 PMC 바로가기 [Article Type] Research